 |
市场调查报告书
商品编码
1547678
全球血管损伤治疗市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测Global Vascular Injury Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
||||||
全球血管损伤治疗市场需求预计将从 2023 年的 43.7 亿美元达到近 77.4 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 6.55%。
血管损伤治疗是一种治疗因外伤或打击造成的血管损伤的方法。血管创伤会对携带血液的动脉和静脉造成轻微或严重的伤害。血管创伤最常见的症状是出血、瘀青和骨折。这些损伤影响动脉、淋巴或静脉系统，最常见于下肢。一些可用的治疗选择包括血管内治疗、筋膜切开术和涉及血管重建的外科手术。血管损伤治疗涉及许多治疗和诊断挑战。血管损伤可能发生在所有年龄层的人中，其中对儿童最具破坏性。
市场动态
创伤是这个快速工业化时代的主要原因之一，也是该市场成长的主要驱动力。需要快速、可靠的血管损伤诊断以实现正确、及时的治疗，这将有利于市场成长。由于经常发生的恐怖攻击，全球平民伤亡人数的增加将推动市场成长。不断增长的医疗支出、更好的护理人员培训将进一步推动市场成长。用于治疗血管创伤患者的优化护理和技术进步将成为市场的助推器。该市场面临的主要挑战是创伤的不及时或漏诊。
研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球血管损伤治疗市场的每个细分市场进行了包容性评估。血管损伤治疗产业的成长和趋势为本研究提供了整体方法。
市场区隔
血管损伤治疗市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。
因受伤
- 痉挛
- 血栓形成
- 挫伤/内膜瓣
- 撕裂/横断
- 动静脉 (AV) 瘻管
- 动脉瘤和假性动脉瘤
- 其他的
按治疗
- 侧动脉缝合术/静脉缝合术
- 额外的解剖搭桥
- 补片血管成形术
- 旁路移植术
- 血栓切除术
- 其他的
按最终用户
- 医院
- 门诊手术中心
- 其他的
区域分析
本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲血管损伤治疗市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。
该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。血管损伤治疗市场的主要参与者包括克利夫兰诊所、阿波罗医院企业有限公司、马萨诸塞州总医院、海德堡大学医院、皇家伯克希尔国民保健服务基金会信託、环球健康服务公司、Tenet Healthcare、梅奥诊所健康系统、Mediclinic International、 CHSPSC LLC、IHH Healthcare Berha。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。
如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。
目录
第一章：前言
- 报告说明
- 客观的
- 目标受众
- 独特的销售主张 (USP) 和产品
- 研究范围
- 研究方法
- 市场研究过程
- 市场研究方法论
第 2 章：执行摘要
- 市集亮点
- 全球市场概况
第 3 章：血管损伤治疗 - 产业分析
- 简介 - 市场动态
- 市场驱动因素
- 市场限制
- 机会
- 产业动态
- 波特五力分析
- 市场吸引力分析
- 按伤害进行的市场吸引力分析
- 按处理方式进行的市场吸引力分析
- 最终用户的市场吸引力分析
- 市场吸引力分析：按地区
第 4 章：价值链分析
- 价值链分析
- 原料分析
- 原料清单
- 原料厂商清单
- 主要原物料价格走势
- 潜在买家名单
- 行销管道
- 直效行销
- 间接行销
- 行销通路发展趋势
第 5 章：全球血管损伤治疗市场分析：按损伤分类
- 按伤害概述
- 按伤害进行历史和预测数据分析
- 痉挛
- 血栓形成
- 挫伤/内膜瓣
- 撕裂/横断
- 动静脉 (AV) 瘻管
- 动脉瘤和假性动脉瘤
- 其他的
第 6 章：全球血管损伤治疗市场分析：依治疗分类
- 按治疗概述
- 依处理方式进行历史与预测资料分析
- 侧动脉缝合术/静脉缝合术
- 额外的解剖搭桥
- 补片血管成形术
- 旁路移植术
- 血栓切除术
- 其他的
第 7 章：全球血管损伤治疗市场分析：依最终使用者分类
- 最终用户概述
- 最终用户的历史和预测数据分析
- 医院
- 门诊手术中心
- 其他的
第 8 章：全球血管损伤治疗市场分析：依地理位置
- 区域展望
- 介绍
- 北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
- 欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
- 亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
- 拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
- 中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析
第 9 章：血管损伤治疗公司的竞争格局
- 血管损伤治疗市场竞争
- 伙伴关係/协作/协议
- 併购
- 新产品发布
- 其他发展
第 10 章：公司简介
- 顶级公司市占率分析
- 市场集中度
- Cleveland Clinic
- 公司概况
- 公司收入
- 产品
- 最新动态
- Apollo Hospitals Enterprise Ltd.
- 公司概况
- 公司收入
- 产品
- 最新动态
- Massachusetts General Hospital
- 公司概况
- 公司收入
- 产品
- 最新动态
- Heidelberg University Hospital
- 公司概况
- 公司收入
- 产品
- 最新动态
- Royal Berkshire NHS Foundation Trust
- 公司概况
- 公司收入
- 产品
- 最新动态
- Universal Health Services Inc.
- 公司概况
- 公司收入
- 产品
- 最新动态
- Tenet Healthcare
- 公司概况
- 公司收入
- 产品
- 最新动态
- Mayo Clinic Health System
- 公司概况
- 公司收入
- 产品
- 最新动态
- Mediclinic International
- 公司概况
- 公司收入
- 产品
- 最新动态
- CHSPSC LLC
- 公司概况
- 公司收入
- 产品
- 最新动态
- IHH Healthcare Berha
- 公司概况
- 公司收入
- 产品
- 最新动态
註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内
The global demand for Vascular Injury Treatment Market is presumed to reach the market size of nearly USD 7.74 Billion by 2032 from USD 4.37 Billion in 2023 with a CAGR of 6.55% under the study period 2024-2032.
Vascular injury treatment is an approach used to treat an injury to the blood vessels caused due to a trauma or a blow. Vascular trauma can cause minor or significant damages to the blood carrying arteries and veins. The most common symptoms of vascular trauma are bleeding, bruising, and fractured bones. These injuries affect the arterial, lymphatic, or venous system and are most often located on a lower limb. Some of the treatment options available are endovascular treatment, fasciotomy, and surgical procedures involving vascular reconstruction. Many therapeutic and diagnostic challenges are involved in vascular injury treatment. Vascular injuries can occur in people of all ages and are the most devastating in children.
MARKET DYNAMICS
Trauma, one of the leading causes of death in this rapid industrialization era, is the main driver for this market's growth. The need for fast and reliable vascular injury diagnosis to enable proper and timely treatment will benefit market growth. The increase in the number of civilian casualties worldwide will boost market growth due to the regular terrorist attack. Growing healthcare spending, better paramedic training will further propel market growth. Optimized care and advancements in technology for treating victims of vascular trauma will be a market booster. The main challenge faced by this market is the untimely or missed diagnosis of the trauma.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Vascular Injury Treatment. The growth and trends of Vascular Injury Treatment industry provide a holistic approach to this study.
MARKET SEGMENTATION
This section of the Vascular Injury Treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Injury
- Spasm
- Thrombosis
- Contusion/Intimal Flap
- Laceration/Transection
- Arteriovenous (AV) Fistula
- Aneurysm and Pseudoaneurysm
- Others
By Treatment
- Lateral Arteriorrhaphy/Venorrhaphy
- Extra Anatomic Bypass
- Patch Angioplasty
- Bypass Graft
- Thrombectomy
- Others
By End User
- Hospitals
- Ambulatory Surgical Centers
- Others
REGIONAL ANALYSIS
This section covers the regional outlook, which accentuates current and future demand for the Vascular Injury Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Vascular Injury Treatment market include Cleveland Clinic, Apollo Hospitals Enterprise Ltd., Massachusetts General Hospital, Heidelberg University Hospital, Royal Berkshire NHS Foundation Trust, Universal Health Services Inc., Tenet Healthcare, Mayo Clinic Health System, Mediclinic International, CHSPSC LLC, IHH Healthcare Berha. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1. PREFACE
- 1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology
2. EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3. VASCULAR INJURY TREATMENT - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Injury
- 3.7.2 Market Attractiveness Analysis By Treatment
- 3.7.3 Market Attractiveness Analysis By End User
- 3.7.4 Market Attractiveness Analysis By Region
4. VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend
5. GLOBAL VASCULAR INJURY TREATMENT MARKET ANALYSIS BY INJURY
- 5.1. Overview By Injury
- 5.2. Historical and Forecast Data Analysis By Injury
- 5.3. Spasm Historic and Forecast Sales By Regions
- 5.4. Thrombosis Historic and Forecast Sales By Regions
- 5.5. Contusion/Intimal Flap Historic and Forecast Sales By Regions
- 5.6. Laceration/Transection Historic and Forecast Sales By Regions
- 5.7. Arteriovenous (AV) Fistula Historic and Forecast Sales By Regions
- 5.8. Aneurysm and Pseudoaneurysm Historic and Forecast Sales By Regions
- 5.9. Others Historic and Forecast Sales By Regions
6. GLOBAL VASCULAR INJURY TREATMENT MARKET ANALYSIS BY TREATMENT
- 6.1. Overview By Treatment
- 6.2. Historical and Forecast Data Analysis By Treatment
- 6.3. Lateral Arteriorrhaphy/Venorrhaphy Historic and Forecast Sales By Regions
- 6.4. Extra Anatomic Bypass Historic and Forecast Sales By Regions
- 6.5. Patch Angioplasty Historic and Forecast Sales By Regions
- 6.6. Bypass Graft Historic and Forecast Sales By Regions
- 6.7. Thrombectomy Historic and Forecast Sales By Regions
- 6.8. Others Historic and Forecast Sales By Regions
7. GLOBAL VASCULAR INJURY TREATMENT MARKET ANALYSIS BY END USER
- 7.1. Overview By End User
- 7.2. Historical and Forecast Data Analysis By End User
- 7.3. Hospitals Historic and Forecast Sales By Regions
- 7.4. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
- 7.5. Others Historic and Forecast Sales By Regions
8. GLOBAL VASCULAR INJURY TREATMENT MARKET ANALYSIS BY GEOGRAPHY
- 8.1. Regional Outlook
- 8.2. Introduction
- 8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
- 8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
- 8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
- 8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
- 8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis
9. COMPETITIVE LANDSCAPE OF THE VASCULAR INJURY TREATMENT COMPANIES
- 9.1. Vascular Injury Treatment Market Competition
- 9.2. Partnership/Collaboration/Agreement
- 9.3. Merger And Acquisitions
- 9.4. New Product Launch
- 9.5. Other Developments
10. COMPANY PROFILES OF VASCULAR INJURY TREATMENT INDUSTRY
- 10.1. Top Companies Market Share Analysis
- 10.2. Market Concentration Rate
- 10.3. Cleveland Clinic
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
- 10.4. Apollo Hospitals Enterprise Ltd.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
- 10.5. Massachusetts General Hospital
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
- 10.6. Heidelberg University Hospital
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
- 10.7. Royal Berkshire NHS Foundation Trust
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
- 10.8. Universal Health Services Inc.
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
- 10.9. Tenet Healthcare
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
- 10.10. Mayo Clinic Health System
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
- 10.11. Mediclinic International
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
- 10.12. CHSPSC LLC
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
- 10.13. IHH Healthcare Berha
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers: Impact Analysis
- Restraints: Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- Analysis By Injury (USD MN)
- Spasm Market Sales By Geography (USD MN)
- Thrombosis Market Sales By Geography (USD MN)
- Contusion/Intimal Flap Market Sales By Geography (USD MN)
- Laceration/Transection Market Sales By Geography (USD MN)
- Arteriovenous (AV) Fistula Market Sales By Geography (USD MN)
- Aneurysm and Pseudoaneurysm Market Sales By Geography (USD MN)
- Others Market Sales By Geography (USD MN)
- Analysis By Treatment (USD MN)
- Lateral Arteriorrhaphy/Venorrhaphy Market Sales By Geography (USD MN)
- Extra Anatomic Bypass Market Sales By Geography (USD MN)
- Patch Angioplasty Market Sales By Geography (USD MN)
- Bypass Graft Market Sales By Geography (USD MN)
- Thrombectomy Market Sales By Geography (USD MN)
- Others Market Sales By Geography (USD MN)
- Analysis By End User (USD MN)
- Hospitals Market Sales By Geography (USD MN)
- Ambulatory Surgical Centers Market Sales By Geography (USD MN)
- Others Market Sales By Geography (USD MN)
- Global Vascular Injury Treatment Market Sales By Geography (USD MN)
- North America Market Analysis (USD MN)
- United States Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate By Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- South East Asia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Vascular Injury Treatment Report
- Market Research Process
- Market Research Methodology
- Global Vascular Injury Treatment Market Size, By Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis By Injury
- Market Attractiveness Analysis By Treatment
- Market Attractiveness Analysis By End User
- Market Attractiveness Analysis By Region
- Value Chain Analysis
- Global Market Analysis By Injury (USD MN)
- Spasm Market Sales By Geography (USD MN)
- Thrombosis Market Sales By Geography (USD MN)
- Contusion/Intimal Flap Market Sales By Geography (USD MN)
- Laceration/Transection Market Sales By Geography (USD MN)
- Arteriovenous (AV) Fistula Market Sales By Geography (USD MN)
- Aneurysm and Pseudoaneurysm Market Sales By Geography (USD MN)
- Others Market Sales By Geography (USD MN)
- Global Market Analysis By Treatment (USD MN)
- Lateral Arteriorrhaphy/Venorrhaphy Market Sales By Geography (USD MN)
- Extra Anatomic Bypass Market Sales By Geography (USD MN)
- Patch Angioplasty Market Sales By Geography (USD MN)
- Bypass Graft Market Sales By Geography (USD MN)
- Thrombectomy Market Sales By Geography (USD MN)
- Others Market Sales By Geography (USD MN)
- Global Market Analysis By End User (USD MN)
- Hospitals Market Sales By Geography (USD MN)
- Ambulatory Surgical Centers Market Sales By Geography (USD MN)
- Others Market Sales By Geography (USD MN)
- Global Market Sales (USD MN)
- North America Market Sales (USD MN)
- Europe Market Sales (USD MN)
- Asia Pacific Market Sales (USD MN)
- Latin America Market Sales (USD MN)
- Middle East & Africa Market Sales (USD MN)
- Recent Development in Industry
- Top Company Market Share Analysis
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
